Latest NewsJun 18, 2025HiFiBiO Therapeutics to Present Preclinical Data of Three Leading I&I Programs at the 2025 Annual Meeting of the Federation of Clinical Immunology SocietiesAll Filter By: Year20252024202320222021202020192018201720162015Nasdaq Live from MarketSite | Interview | Jan 7, 2024CEO Liang Schweizer Sits with Nasdaq to Share HiFiBiO Therapeutics’ Mission to Unlock the Curative Powers of the Immune SystemDec 11, 2023HiFiBiO Therapeutics Collaborates with Institut Gustave Roussy and France 2030 Initiative to Pioneer Personalized ImmunotherapiesNov 8, 2023HiFiBiO Therapeutics Drug Intelligence Science DIS® Platform Wins “AI Innovation of the Year” in 2023 BioTech Breakthrough AwardsOct 23, 2023Drug Intelligence Science (DIS®) – A Cutting-Edge Translational Platform Pioneered by HiFiBiO Therapeutics – Featured in Drug Discovery TodayOct 9, 2023HiFiBiO Therapeutics Receives Approval from Chinese NMPA for IND Application for HFB200301, an Innovative Anti-Tumor Monoclonal Antibody< 1 2 3 4 5 … 17 >
